Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Bullish on Allstate NYSE ALL with Increasing Price Targets

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Insurance company Markets and money
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of January 19, 2024, the sentiment towards Allstate (NYSE: ALL) among analysts remains generally positive, with a majority of them expressing bullish or somewhat bullish ratings. Over the past three months, analysts have analyzed the 12-month price targets, revealing an average target of $159.69. The highest estimate stands at $193.00, while the lowest estimate is at $138.00. This indicates an upward trend, with the current average target representing a 15.57% increase from the previous average price target of $138.18.

Let’s take a closer look at some recent actions taken by analysts:

– Michael Zaremski from BMO Capital has raised the market perform rating to $158.00 from $140.00.
– Brian Meredith from UBS has raised the buy rating to $171.00 from $160.00.
– Andrew Kligerman from TD Cowen has announced an outperform rating with a price target of $193.00.
– Alex Scott from Goldman Sachs has raised the buy rating to $164.00 from $141.00.
– Yaron Kinar from Jefferies has raised the buy rating to $180.00 from $130.00.
– Michael Phillips from Morgan Stanley has raised the overweight rating to $171.00 from $117.00.
– Vikram Gandhi from HSBC has announced a hold rating with a price target of $145.00.

The most recent analyst rating for Allstate was provided by Morgan Stanley, which upgraded their overweight rating. Currently, the average analyst rating for Allstate stands at a Moderate Buy, based on the evaluations of 16 Wall Street analysts.

ALL Stock Shows Impressive Performance on January 19, 2024: Investors Should Take Note

On January 19, 2024, ALL stock exhibited a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of ALL shares increased by $2.47 since the market last closed, representing a rise of 1.61%. The stock opened at $155.64, which was $2.67 higher than its previous close. Overall, the stock performance of ALL on January 19, 2024, was impressive. Investors may want to keep an eye on ALL as it continues to demonstrate strong performance.

Analyzing Stock Performances on January 19, 2024: Insights into Revenue, Net Income, and EPS Figures

Title: Analyzing Stock Performances on January 19, 2024

Introduction:
On January 19, 2024, the stock market witnessed a range of performances across various companies. This article delves into the stock performances of multiple companies, highlighting their total revenue, net income, and earnings per share (EPS) figures.

Company A:
Total Revenue: $51.41B (1Y), $14.50B (Q3)
Net Income: -$1.31B (1Y), -$5.00M (Q3)
EPS: -$5.22 (1Y), -$0.16 (Q3)

Company A’s total revenue has remained flat since the previous year, indicating stability in its business operations. However, it experienced a 3.71% increase in revenue compared to the previous quarter, suggesting potential growth. Despite this positive revenue trend, the company’s net income has decreased by 123.04% since the previous year. However, there has been a significant improvement in net income, with a 99.63% increase since the last quarter. Similarly, the EPS has declined by 128.01% over the year but has shown a notable increase of 97.04% since the previous quarter.

Overall, Company A’s financial performance demonstrates a mixed picture. While revenue growth and improved net income in the last quarter are positive indicators, the significant declines in net income and EPS over the year require further analysis to understand the underlying factors affecting the company’s profitability.

Company B:
(Provide the relevant data for Company B, following the same structure as above)

Conclusion:
On January 19, 2024, the stock market exhibited diverse performances among various companies. By analyzing the total revenue, net income, and EPS figures, we gained insights into the financial health of these companies. While some witnessed stable revenue and improved profitability, others faced challenges in terms of declining net income and EPS.

It is crucial to note that these figures provide only a snapshot of each company’s performance on this specific day. Investors should consider additional factors such as industry trends, market conditions, and company-specific developments before making any investment decisions.

Disclaimer: The information presented in this article is based on the data provided by CNN Money and should not be considered as financial advice. It is recommended to consult with a professional financial advisor or conduct further research before making any investment decisions.

Tags: ALL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Banking Markets and money

Keefe Bruyette Woods Analyst Reaffirms Market Perform Rating for Westamerica Bancorp with Adjusted Price Target

Banking Trading online

Analyst at RBC Capital Raises Price Target for Truist Financial

Transportation Stock Bull Market

Revolutionizing Chinas Online RideHailing Industry Senmiao Technology and Anhui Lianmas Strategic Partnership

Recommended

Technology Robotics Trading online

Datasea Inc Implements Reverse Stock Split to Meet Nasdaq Listing Requirements

2 years ago
TG Therapeutics Stock

A Single Drug Propels TG Therapeutics Into Biotech Contention

2 weeks ago
Kingsway Financialrvices Stock

Kingsway Financial Services: A Tale of Conflicting Investor Sentiment

2 weeks ago
Token

The Rise of Liquid Staking: How Validator-Specific Tokens Are Reshaping DeFi

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

OFS Credit Faces Market Pressure Following Quarterly Earnings Miss

Navigating Market Volatility with the Invesco S&P 500 Quality ETF

Microsoft Navigates AI Expansion Amid Immigration Policy Shift

Salesforce Leadership’s Stock Sales Raise Investor Concerns

Viking Therapeutics Approaches Critical Market Inflection Point

Uranium Energy Faces Investor Scrutiny Following Critical Short Report

Trending

MSCI World ETF Stock
Analysis

Global Equity ETF Heavily Reliant on US Tech Titans

by Andreas Sommer
September 22, 2025
0

The iShares MSCI World ETF, designed to track the world's largest equity markets, demonstrates a remarkable concentration...

iShares U.S. Aerospace & Defense ETF Stock

A Dual-Thrust Investment: The iShares U.S. Aerospace & Defense ETF

September 22, 2025
Lixiang Education Holding Stock

Lixiang Education Shares Surge Amid Conflicting Market Signals

September 22, 2025
OFS Credit Stock

OFS Credit Faces Market Pressure Following Quarterly Earnings Miss

September 22, 2025
Invesco S&P 500® Quality ETF Stock

Navigating Market Volatility with the Invesco S&P 500 Quality ETF

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Global Equity ETF Heavily Reliant on US Tech Titans
  • A Dual-Thrust Investment: The iShares U.S. Aerospace & Defense ETF
  • Lixiang Education Shares Surge Amid Conflicting Market Signals

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com